Attain Performa(TM) Quadripolar Lead Study

Trial ID or NCT#



recruiting iconRECRUITING


The purpose of the study is to evaluate the safety and efficacy of the Medtronic Attain Performa Quadripolar Leads (Model 4298, 4398, and 4598) during and post the implant procedure. This study will also assess the interactions of the Attain Performa leads with the entire Medtronic CRT-D system.

Official Title

Attain Performa(TM) Quadripolar Lead Study

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Patient is indicated for implant of a CRT-D device and left-heart lead per local indications (In US only this is based on Class I and II indications for CRT-D implant per HRS/ACC/AHA guidelines) - Patient (or legally authorized representative) has signed and dated the study-specific Consent Form - Patient is 18 years of age or older, or is of legal age to give informed consent per local and national law - Patient is expected to remain available for follow-up visits - Patient understands the study and agrees to comply with study protocol
Exclusion Criteria:
  1. - Patient has a previous LV lead implanted or previous implant attempt within 30 days of enrollment or has ongoing AEs from a previous unsuccessful implant attempt - Patient has contraindications for standard transvenous cardiac pacing (e.g., mechanical right heart valve) - Patient has had a heart transplant (Note: Patients waiting for heart transplants are allowed in the study) - Patient is contraindicated for < 1 mg dexamethasone acetate - Patient is currently enrolled or planning to participate in a potentially confounding drug or device study during the course of this study. (Note: Co-enrollment in concurrent studies may be allowed provided that documented pre-approval is obtained from Medtronic's study manager) - Patient has a life expectancy less than 180 days - Patient with exclusion criteria required by local law (e.g. age, pregnancy, breast feeding, etc.) - In US, women of childbearing potential must have a negative pregnancy test 7 days prior to implant to be included - Patient is unable to tolerate an urgent thoracotomy


Marco Perez
Marco Perez
Cardiac electrophysiologist
Associate Professor of Medicine (Cardiovascular Medicine)

Contact us to find out if this trial is right for you.


Linda Norton, RN, MSN
(650) 725-5597